Company
PT Millennium Pharmacon International Tbk
Headquarters: Jakarta Selatan, Indonesia
Employees: 922
Market Cap
Rp206.39 Billion
IDR as of Jan. 1, 2024
US$13.4 Million
PT Millennium Pharmacon International Tbk Categories
Indonesia Healthcare Medical DistributionIndonesia Healthcare Indonesia Medical Distribution
Top Competitors by Market Capitalization
Industry: Medical Distribution
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, food supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2020, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
PT Millennium Pharmacon International Tbk has the following listings and related stock indices.
Stock: IDX: SDPC wb_incandescent